https://www.lonsurfhcp.com/resources/clinical-resources Navigating 3L Treatment Options for Patients Living With mCRC Watch oncologist Dr. John Marshall discuss the 3L treatment landscape for mCRC, why he chooses LONSURF plus bevacizumab based on the SUNLIGHT data, and tips on how he gets the dose right. https://www.youtube.com/watch?v=QcC2cZ-jCMk 658 Importance of Timely Intervention in Patients With Refractory mCRC Watch oncologist Dr. Marwan Fakih address the importance of starting systemic therapy at the first sign of progression while patients are maintaining good ECOG PS and why he chooses LONSURF + bevacizumab in 3L based on the SUNLIGHT data. https://www.youtube.com/watch?v=D9r_WPj-FVA 677